Similarly, Parkinson’s disease (PD) shows differentially methylated genes such as SNCA, which are consistently hypomethylated in both peripheral blood and brain tissue, suggesting a potential biomarker for PD progression [4]. Here, SNCA is linked to Parkinson disease.